<--- Back to Details
First PageDocument Content
Date: 2018-02-25 01:50:36

XOFLUZATM (Baloxavir Marboxil) Tablets 10mg/20mg Approved for the Treatment of Influenza Types A and B in Japan Osaka, Japan, February 23, Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao Teshirogi,

Add to Reading List

Source URL: isirv.org

Download Document from Source Website

File Size: 81,08 KB

Share Document on Facebook

Similar Documents